Drug utilization and prescribing pattern in the treatment of urolithiasis: a perspective on World Health Organization recommendations

Simple item page
dc.contributor.authorSada, M.en_US
dc.contributor.authorKhan, S.en_US
dc.contributor.authorKhan, M. U.en_US
dc.contributor.authorKhan, M. M.en_US
dc.contributor.authorKumar, P.en_US
dc.contributor.authorAhmad, U.en_US
dc.date.accessioned2024-09-24T06:13:54Z
dc.date.available2024-09-24T06:13:54Z
dc.date.issued2024-06
dc.description.abstractBackground: Drug utilization research (DUR) is essential in promoting rational use of medicine, aimed at understanding the patterns of prescription, administration, and utilization of medications. It provides valuable insights into the actual drug usage patterns for specific disease conditions. To evaluate the current utilization pattern of drugs in patients of urolithiasis in the Department of General Medicine and Surgery at Integral Institute of Medical Science and Research Hospital, Lucknow. Methods: Following the approval of the institutional ethics committee, a prospective observational study was conducted at Integral Institute of Medical Science and Research Department of general medicine and surgery over a six-month period. Urolithiasis patients’ prescriptions were analyzed to study the prescribing patterns. Information about patient demographics, co-morbidities, and the number and types of medications prescribed were collected and analyzed. Results: Out of 102 patients studied, a female preponderance over male patients was observed. The co-morbidities that are encountered most commonly were hydronephrosis, cystitis, and renal cyst. There is averaged 7 medicines per prescription, 15.25% of medicines written by the generic name, 83.33% of patients receiving antibiotics, 54.70% of patients receiving injections, and 83% of drugs prescribed are mentioned in the essential medicine list. Analgesics, antibiotics, nutritional supplements, antiemetic, alkalizing agents, and antispasmodics were among the class of medicines given. Conclusions: This study highlights the current use of medicines and drug utilization in urolithiasis management. The findings show important insights for healthcare professionals to enhance medication therapy, encourage cost-effective healthcare delivery and improve quality of patient in urolithiasis management.en_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of Pharmacy Practice, Integral University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsFaculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsDepartment of General Surgery, Integral Institute of Medical Science and Research Hospital, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.affiliationsFaculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, Indiaen_US
dc.identifier.citationSada M., Khan S., Khan M. U., Khan M. M., Kumar P., Ahmad U.. Drug utilization and prescribing pattern in the treatment of urolithiasis: a perspective on World Health Organization recommendations. International Journal of Basic & Clinical Pharmacology. 2024 May; 13(3): 371-377en_US
dc.identifier.issn2319-2003
dc.identifier.issn2279-0780
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/226746
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber3en_US
dc.relation.volume13en_US
dc.source.urihttps://doi.org/10.18203/2319-2003.ijbcp20240994en_US
dc.subjectUrolithiasisen_US
dc.subjectDrug utilizationen_US
dc.subjectPrescribing patternen_US
dc.subjectKidney stonesen_US
dc.subjectPrescribing indicatorsen_US
dc.titleDrug utilization and prescribing pattern in the treatment of urolithiasis: a perspective on World Health Organization recommendationsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijbcp2024v13n3p371.pdf
Size:
278.52 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Basic & Clinical Pharmacology